About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Stingless Bee Honey Augmentation in Major Depressive Disorders

Stingless Bee Honey Augmentation in Major Depressive Disorders

NCT06723249·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospital Universiti Sains Malaysia

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adults with ages 18 to 65
with Major Depressive Disorder with scores of Beck Depression Inventory Malay version equal or more than 11

You may not be if

Women in pregnancy or breast-feeding.
Patients who with honey allergy or stingless bee honey allergy.
Currently taking honey not limited to stingless bee honey or taken honey not limited to stingless bee honey in the past one month.
comorbidity either with generalized anxiety disorder,
panic disorder,
social anxiety disorder,
bipolar disorder,
substance-use disorder,
suicidal ideation or attempt,
dementia,
Alzheimer disease,
diabetic,
hypertension,
chronic kidney disease

The record

StatusCompleted

PhaseNo phase

Taking part45

StartedDec 2024

UpdatedDec 23, 2025

Conditions

Major Depressive Disorder (MDD)

Where1

Hospital Universiti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia